Growth Metrics

Ultralife (ULBI) Equity Average (2016 - 2025)

Ultralife has reported Equity Average over the past 15 years, most recently at $133.6 million for Q4 2025.

  • Quarterly results put Equity Average at $133.6 million for Q4 2025, down 0.51% from a year ago — trailing twelve months through Dec 2025 was $133.6 million (down 0.51% YoY), and the annual figure for FY2025 was $132.0 million, up 1.76%.
  • Equity Average for Q4 2025 was $133.6 million at Ultralife, down from $138.0 million in the prior quarter.
  • Over the last five years, Equity Average for ULBI hit a ceiling of $138.0 million in Q3 2025 and a floor of $115.9 million in Q1 2023.
  • Median Equity Average over the past 5 years was $120.7 million (2023), compared with a mean of $124.9 million.
  • Biggest five-year swings in Equity Average: dropped 2.22% in 2022 and later grew 11.1% in 2024.
  • Ultralife's Equity Average stood at $118.1 million in 2021, then dropped by 1.6% to $116.2 million in 2022, then grew by 6.37% to $123.6 million in 2023, then rose by 8.67% to $134.3 million in 2024, then decreased by 0.51% to $133.6 million in 2025.
  • The last three reported values for Equity Average were $133.6 million (Q4 2025), $138.0 million (Q3 2025), and $137.6 million (Q2 2025) per Business Quant data.